Skip to main content

Table 3 Demographics and salivary secretion rates for patients selected for mucin O-glycosylation analysis

From: Stimulated saliva composition in patients with cancer of the head and neck region

Code Sex Age Tumor site TNM, stage Treatment Stimulated salivary secretion rate (ml/min)
Pretreat 6 mo 1 year 2 years
1 M 55 Tumor colli T0N2M0, st IV S, ERT 2.4 0.5 0.8 1.1
2 M 65 Tonsil T2N1M0, st II C, ERT 2.3 0.7 1.9 1.6
3 F 47 Tonsil T2N0M0, st II ERT 1.9 0.7 0.6 1.0
4 M 43 Nasopharynx T3N2M0, st III C, ERT 2.4 0.7 1.0 1.0
5 F 66 Tonsil T2N2M0, st IV C, ERT 1.6 0.3 0.8 0.7
6 M 54 Tonsil T2N2bM0, st IV C, ERT 0.9 0.3 0.3 0.5
  1. S surgery, ERT external radiation therapy, C cytostatics